Trade Report: The Blue Fin Capital Inc. Maintains Position in HCP Inc. (HCP)

The Blue Fin Capital Inc. Maintains Position in HCP Inc. (HCP)

Blue Fin Capital Inc. continued to hold its stake in shares of HCP Inc. (NYSE:HCP) during the second quarter, Holdings Channel reports. The firm owned 8,930 shares of the real estate investment trust’s stock at the end of the second quarter. Blue Fin Capital Inc.’s holdings in HCP were worth $316,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of HCP. DT Investment Partners LLC boosted its stake in shares of HCP by 21.3% in the second quarter. DT Investment Partners LLC now owns 28,307 shares of the real estate investment trust’s stock worth $1,002,000 after buying an additional 4,971 shares during the last quarter. Henderson Group PLC boosted its stake in shares of HCP by 23.2% in the second quarter. Henderson Group PLC now owns 76,454 shares of the real estate investment trust’s stock worth $2,705,000 after buying an additional 14,395 shares during the last quarter. Hedeker Wealth LLC boosted its stake in shares of HCP by 1.5% in the second quarter. Hedeker Wealth LLC now owns 12,570 shares of the real estate investment trust’s stock worth $445,000 after buying an additional 190 shares during the last quarter. Concert Wealth Management Inc. boosted its stake in shares of HCP by 16.3% in the second quarter. Concert Wealth Management Inc. now owns 73,030 shares of the real estate investment trust’s stock worth $2,595,000 after buying an additional 10,245 shares during the last quarter. Finally, Real Estate Management Services LLC acquired a new stake in shares of HCP during the second quarter worth about $3,757,000. 90.97% of the stock is currently owned by institutional investors and hedge funds.

HCP Inc. (NYSE:HCP) traded up 0.30% during trading on Monday, reaching $36.35. 1,624,606 shares of the company were exchanged. HCP Inc. has a 1-year low of $25.11 and a 1-year high of $40.43. The stock’s market capitalization is $17.00 billion. The company’s 50-day moving average price is $37.93 and its 200-day moving average price is $36.18.

HCP (NYSE:HCP) last posted its earnings results on Tuesday, August 9th. The real estate investment trust reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.04. HCP had a negative net margin of 2.52% and a negative return on equity of 0.67%. The firm had revenue of $662.20 million for the quarter, compared to the consensus estimate of $631.25 million. During the same period in the previous year, the firm posted $0.79 EPS. The business’s quarterly revenue was up 9.0% on a year-over-year basis. On average, equities analysts forecast that HCP Inc. will post $2.82 EPS for the current year.

Several research firms have recently weighed in on HCP. Vetr raised shares of HCP from a “sell” rating to a “hold” rating and set a $36.58 price target on the stock in a report on Thursday. Zacks Investment Research cut shares of HCP from a “buy” rating to a “hold” rating in a report on Thursday, October 6th. Bank of America Corp. raised shares of HCP from an “underperform” rating to a “neutral” rating and set a $38.50 price target on the stock in a report on Tuesday, October 4th. Argus reaffirmed a “hold” rating on shares of HCP in a report on Sunday, September 18th. Finally, Wells Fargo & Co. reaffirmed a “hold” rating on shares of HCP in a report on Sunday, September 4th. Six research analysts have rated the stock with a sell rating, thirteen have given a hold rating and one has given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $34.74.

In other news, insider Kendall K. Young sold 9,000 shares of the business’s stock in a transaction dated Wednesday, August 24th. The shares were sold at an average price of $39.46, for a total value of $355,140.00. Following the sale, the insider now directly owns 36,183 shares in the company, valued at approximately $1,427,781.18. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Thomas D. Kirby sold 3,000 shares of the business’s stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $40.24, for a total transaction of $120,720.00. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by insiders.

HCP Company Profile

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

Related posts

Leave a Comment